Brighter Future
Newsroom
Careers
Investors
Patients
HCPs
Worldwide
Who We Are
About Takeda
How can we do more for our patients?
Everything at Takeda starts with this question.
Learn more
Company Information
Company Facts
History
Worldwide Offices
Executive Leadership
Positions
How We Work
Life at Takeda
Design Concept
Where we work
Corporate Philosophy
Our People
Corporate Governance
Risk & Crisis Management
Global Ethics & Compliance
From the CEO
Contact Us
LEARN MORE
What We Do
Our Business
Takeda continues its transformation into an agile and innovative global pharmaceutical leader, serving the needs of patients and physicians worldwide.
Learn more
Research & Development
Ecosystem for Health Innovation
Our Pipeline
Takeda Clinical Trial Transparency
Investigator Initiated Sponsored Research
Therapeutic  Areas
Our Products
Alliances &  Partnerships
Access to Medicines
Suppliers
Sustainable Procurement
Supplier Code of Conduct
Supplier Diversity
Pharmaceutical Supply Chain Initiative
Supplier Qualification & Due Diligence
T-CiRA
LEARN MORE
Our Stories
Our Stories
A selection of stories related to Innovation, Caring and Heritage
Learn more
Innovation
Quality at Takeda
The Key Elements at the Heart of Our Innovation
Caring
Medicine for the World
Safeguarding Plant Diversity
Takeda at TICAD
Going Beyond Medicines
Change the World
Healthcare for All
Shared Knowledge for a Better Life for All
Heritage
Keys to Aging Gracefully
LEARN MORE
Corporate Responsibility
Takeda's CSR
Takeda is committed to creating corporate value by developing outstanding pharmaceutical products and conducting corporate citizenship activities.
LEARN MORE
Our CSR Philosophy
Human Rights
Labor
Environment
Anti-Corruption
Activities
Global CSR Program
SDGs
Takeda Initiative
IDEEL Program
HERhealth
Global Relay for Life
Digital Birth Registration
Corporate Citizenship Videos
Sustainable Value Report
LEARN MORE
Message from the CEO
Proposed Acquisition of Shire to Accelerate Our Transformation
LEARN MORE
Welcome to the global
corporate site for Takeda.
If you are looking for specific information,
please visit our country/region website.
SELECT A COUNTRY OR REGION SITE
LEARN MORE
LEARN MORE
RECENT NEWS
STOCK PRICE
Takeda Announces Publication of Circular and Notice of Extraordinary General Meeting of Shareholders in relation to the Proposed Acquisition of Shire
GO TO NEWSROOM

                        Stock Quotes 
(real-time)
TSE 1st
Chart
Error...
Topics
LEARN MORE
LEARN MORE
LEARN MORE
LEARN MORE
Information
To Our Shareholders and Investors regarding the Proposed Acquisition of Shire
Announcement of 2
nd
 Quarter Financial Results of FY2018 on October 31
st
, 2018
Financial Results Announcement (3:00 pm JST)
Conference Call on Financial Results (For Media: 4:15  pm - 5:00 pm JST / For Investors & Analysts: 5:30 pm - 7:00 pm JST)
Presenters: Christophe Weber, President & CEO, and others
Committed to Sustainability: 2018 Sustainable Value Report Published
Offer for Shire plc
TOP
Terms of Use
Website Privacy Notice
Connect with us:
linkedin
twitter
Worldwide
We use cookies to gather web statistics that help us improve our site. We store no personal details.
Accept
Read more